Mura Chiara, Rodia Rossella, Corrias Silvia, Cappai Antonello, Lai Maria Letizia, Canu Gian Luigi, Medas Fabio, Calò Pietro Giorgio, Mariotti Stefano, Boi Francesco
Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, 09100 Cagliari, Italy.
Pathology Unit, San Giovanni di Dio Hospital, 09100 Cagliari, Italy.
Cancers (Basel). 2024 Jan 2;16(1):210. doi: 10.3390/cancers16010210.
The FNA-CT is useful for the diagnosis of MTC. The aim of this study was to evaluate the performance of FNA-CT in TNs coexisting with CCH.
This study retrospectively reviewed the records of 11 patients with TNs submitted to thyroidectomy on the basis of elevated basal and/or stimulated serum CT values, which at histology were not confirmed to be MTC. The results obtained in this group were compared with those of a previously reported group of histologically proven MTC patients submitted to an identical presurgical evaluation. All patients, negative for known mutations in the RET proto-oncogene, were preoperatively submitted to neck ultrasound, FNA-cytology, and FNA-CT.
Approximately 6 of 11 patients showed increased (>36 ng/mL, as established in previous studies not involving patients with CCH) FNA-CT. All these patients showed diffuse CCH at histology in the thyroid lobe submitted to FNA; 5 of them were benign at histology, while only one was malignant (papillary thyroid carcinoma, PTC). The remaining 5 of 11 patients had low FNA-CT (<36 ng/mL), and all of them showed only focal CCH in the lobe submitted to FNA; three of them were malignant (2 PTC, 1 follicular carcinoma), while two were benign.
Employing the currently proposed cut-off values, false-positive FNA-CT results may be observed in benign/malignant TNs with coexisting diffuse CCH. FNA-CT must therefore be cautiously used in the diagnostic approach for patients with TNs and a slightly increased basal or stimulated serum CT concentration in order to avoid unnecessary surgery.
细针穿刺活检联合降钙素检测(FNA-CT)对甲状腺髓样癌(MTC)的诊断很有用。本研究的目的是评估FNA-CT在与慢性淋巴细胞性甲状腺炎(CCH)共存的甲状腺结节(TNs)中的诊断效能。
本研究回顾性分析了11例因基础和/或刺激后的血清降钙素值升高而接受甲状腺切除术的TNs患者的记录,组织学检查未证实为MTC。将该组患者的结果与先前报道的一组经组织学证实为MTC且接受相同术前评估的患者的结果进行比较。所有患者RET原癌基因已知突变均为阴性,术前均接受颈部超声、细针穿刺细胞学检查和FNA-CT检查。
11例患者中约6例FNA-CT升高(>36 ng/mL,如先前不涉及CCH患者的研究所确定)。所有这些患者在接受FNA检查的甲状腺叶组织学检查中均显示弥漫性CCH;其中5例组织学检查为良性,而只有1例为恶性(乳头状甲状腺癌,PTC)。11例患者中其余5例FNA-CT较低(<36 ng/mL),并且他们在接受FNA检查的叶中均仅显示局灶性CCH;其中3例为恶性(2例PTC,1例滤泡癌),而2例为良性。
采用目前建议的临界值,在伴有弥漫性CCH的良性/恶性TNs中可能会观察到FNA-CT结果假阳性。因此,在诊断伴有基础或刺激后血清降钙素浓度略有升高的TNs患者时,必须谨慎使用FNA-CT,以避免不必要的手术。